Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Head & Neck 4Thoracic 2Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 3Urologic Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Leukemia 1Head and Neck Neoplasms 1

Interventions

pembrolizumab 19Docetaxel 9atezolizumab 8Cetuximab 8Nivolumab 7cemiplimab 6Ipilimumab 4Immune Checkpoint Inhibitors 4Gemcitabine 4Drug Therapy 4spartalizumab 3palbociclib 3fludarabine 3durvalumab 3avelumab 3Trastuzumab 3Radiotherapy 3Paclitaxel 3Oncolytic Virotherapy 3Irinotecan 3Fulvestrant 3Fluorouracil 3Cyclophosphamide 3Carboplatin 3Bortezomib 3Blood Specimen Collection 3seribantumab 2selpercatinib 2pazopanib 2motexafin gadolinium 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Tissue Banks × Breast × Clear all
NCT06827639 2025-02-14

FUTURE

Assistance Publique Hopitaux De Marseille

Not yet recruiting
640 enrolled
BreastGastrointestinalGenitourinaryHead & NeckLymphoidOther hematologic neoplasmThoracic

Breast Neoplasms, Head and Neck Neoplasms, Leukemia, Liver Neoplasms, Lung Neoplasms, Lymphoma, Stomach Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡